The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis C

Journal of Molecular Medicine

Volumn 74, Issue 10, 1996, Pages 583-588

  Diepolder, H M ^a   Zachoval, R ^a   Hoffmann, R M ^a   Jung, M C ^a   Gerlach, T ^b   Pape, G R ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

CD4+ T cells; Hepatitis C; Hepatitis C virus; Immune response; T cell vaccine

Indexed keywords

CD4 ANTIGEN;

HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; REVIEW; T LYMPHOCYTE; VIRUS INFECTION;

ACUTE DISEASE; ANIMALS; ANTIGEN PRESENTATION; CHRONIC DISEASE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0029808747     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050062     Document Type: Review

References (54)

1. Alter MJ (1995) Epidemiology of hepatitis C in the West. Semin Liver Dis 15:5-14
2. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mures A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, Meeks EL, Beach MJ (1992) The natural history of community-aquired hepatitis C in the United States. N Engl J Med 327:1899-1905
3. Fried MW, Hoofnagle JH (1995) Therapy of hepatitis C. Semin Liver Dis 15:82-91
4. Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mtishahwar IK, Desai SM, Miller RH, Ogata N, Purcell RH (1991) Lack of protective immunity against reinfection with hepatitis C virus. Science 258:135-140
5. Farci P, Alter HJ, Wong DC, Miller RH, Govindarajan S, Engle R, Shapiro M, Purcell RH (1994) Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci USA 91:7792-7796
6. Prince AM (1994) Challenges for development of hepatitis C virus vaccines. FEMS Microbiol Rev 14:273-278
7. Prince AM (1994) Immunity in hepatitic C virus infection. Vox Sang 67 [Suppl 3]:227-228
8. Lai ME, Mazzoleni AP, Argiolu F, De Virgilis S, Balestrieri A, Purcell RH, Cao A, Farci P (1994) Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 343:388-390
9. Choo Q-L, Kuo G, Ralston R, Weiner A, Chien D, Van Nest G, Han J, Berger K, Thudium K, Kuo C, Kansopon J, McFarland J, Tabrizi A, Ching K, Moss B, Cummins LB, Houghton M, Muchmore E (1994) Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci USA 91:1294-1298
10. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H (1994) Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 68:1494-1500
11. Maertens G, Ducatteeuw A, Barlet V, Zarski J-P, de Martynoff G, Bosman F, Stuyver L, Brouwer JT, Heijtink RA (1995) E1 antibody level monitoring predicts long-term resolution of hepatitis C virus infection. J Hepatol 23 [Suppl 1]:88 (abstract)
12. Simmonds P (1995) Variability of hepatitis C virus. Hepatology 21:570-583
13. Koziel MJ, Liang TJ (1994) Vaccination against hepatitis C virus infection: miles to go before we sleep. Hepatology 20:758-760
14. Vallari DS, Jett BW, Alter HJ, Mimms LT, Holzman R, Shih JW (1992) Serological markers of posttransfusion hepatitis C viral infection. J Clin Microbiol 30:552-556
15. Mondelli MU, Cerino A, Boender P, Oudshoorn P, Middeldorp J, Fipaldini C, La Monica N, Habets W (1994) Significance of the immune response to a major, conformational B-cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody. J Virol 68:4829-4836
16. Vitiello A, Ishioka G, Grey HM, Rose R, Farness P, LaFond R, Yuan L, Chisari FV, Furze J, Bartholomeuz R, Chesnut RW (1995) Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. J Clin Invest 95:341-349
17. Koziel MJ, Dudley D, Afdhal N, Choo Q-L, Houghton M, Ralston R, Walker BD (1993) Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 67:7522-7532
18. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD (1992) Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronichepatitis. J Immunol 149:3339-3344
19. Cerny A, McHutchison JG, Pasquinelli C, Brown ME, Brothers MA, Grabscheid B, Fowler P, Houghton M, Chisari FV (1995) Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Invest 95:521-530
20. Battegay M, Fikes J, Di Bisceglie AM, Wentworth PA, Sette A, Celis E, Ching W-M, Grakoui A, Rice CM, Kurokohchi K, Berzofsky JA, Hoofnagle JH, Feinstone SM, Akatsuka T (1995) Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J Virol 69:2462-2470
21. Kita H, Moriyama T, Kaneko T, Harase I, Nomura M, Miura H, Nakamura I, Yazaki Y, Imawari M (1993) HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology 18:1039-1044
22. Chien Y, Davis MM (1993) How aβ T-cell receptors 'see' peptide/MHC complexes. Immunol Today 14:597-602
23. Neefjes JJ, Ploegh HL (1992) Intracellular transport of MHC class II molecules. Immunol Today 13:179-184
24. Benham A, Tulp A, Neefjes J (1995) Synthesis and assembly of MHC-peptide complexes. Immunol Today 16:359-362
25. Sinigaglia F, Hammer J (1994) Defining rules for the peptide-MHC class II interaction. Curr Opin Immunol 6:52-56
26. Rammensee H-G, Friede T, Stevanovic S (1995) MHC ligands and peptide motifs: first listing. Immunogenetics 41:178-228
27. Romagnani S (1991) Human TH1 and TH2 subsets: doubt no more. Immunol Today 12:256-257
28. H2 cells. J Clin Immunol 15:121-129
29. Kelso A (1995) Th1 and Th2 subsets: paradigms lost. Immunol Today 16:374-379
30. Murray JS, Pfeiffer C, Madri J, Bottomly K (1992) Major histocompatibility (MHC) control of CD4 T cell subset activation. II. A single peptide induces either humoral or cell-mediated responses in mice of distinct MHC genotype. Eur J Immunol 22:559-565
31. Pfeiffer C, Stein J, Southwood S, Ketelaar H, Sette A, Bottomly K (1995) Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med 181:1569-1574
32. Manetti R, Parronchi P, Giudizi MG, Piccinni M-P, Maggi E, Trinchieri G, Romagnani S (1993) Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 177:1199-1204
33. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549
34. Sypek JP, Chung CL, Mayor SEH, Subramanyam JM, Goldman SJ, Sieburth DS, Wolf SF, Schaub RG (1993) Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med 177:1797-1802
35. O'Garra A, Murphy K (1994) Role of cytokines in determining T-lymphocyte function. Curr Opin Immunol 6:458-466
36. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH (1995) B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707-718
37. Kawamura T, Furue M (1995) Comparative analysis of B7-1 and B7-2 expression in Langerhans cells: differential regulation by T helper type 1 and T helper type 2 cytokines. Eur J Immunol 25:1913-1917
38. + cell response against human immunodeficiency virus: implications for long-term survival. Proc Natl Acad Sci USA 92:11135-11139
39. H2 switch is a critical step in the etiology of HIV infection. Immunol Today 14:107-111
40. Simmonds P, Holmes EC, Cha T-A, Chan S-W, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS (1993) Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74:2391-2399
41. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, Chan S-W, Chayama K, Chen D-S, Choo Q-L, Colombo M, Cuypers HTM, Date T, Dusheiko GM, Esteban JI, Fay O, Hadziyannis SJ, Han J, Hatzakis A, Holmes EC, Hotta H, Houghton M, Irvine B (1994) A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19:1321-1324
42. McOmish F, Yap PL, Dow BC, Follett EAC, Seed C, Keller AJ, Cobain TJ, Krusius T, Kolho E, Naukkarinen R, Lin C, Lai C, Leong S, Medgyesi GA, Héjjas M, Kiyokawa H, Fukada K, Cuypers T, Saeed AA, Al-Rasheed AM, Lin M, Simmonds P (1994) Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 32:884-892
43. Chemello L, Alberti A, Rose K, Simmonds P (1994) Hepatitis C serotype and response to interferon therapy. N Engl J Med 330:143
44. Koizumi K, Enomoto N, Kurosaki M, Murakami T, Izumi N, Marumo F, Sato C (1995) Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology 22:30-35
45. Botarelli P, Brunetto MR, Minutello MA, Calvo P, Unutmaz D, Weiner AJ, Choo Q-L, Sinister JR, Kuo G, Bonino F, Houghton M, Abrignani S (1993) T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 104:580-587
46. Ferrari C, Valli A, Galati L, Penna A, Scaccaglia P, Giuberti T, Schianchi C, Missale G, Marin MG, Fiaccadori F (1994) T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 19:286-295
47. + T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med 178:17-25
48. + T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology 21:632-638
49. Iwata K, Wakita T, Okumura A, Yoshioka K, Takayanagi R, Wands JR, Kakumu S (1995) Interferon gamma production by peripheral blood lymphocytes to hepatitis C virus core protein in chronic hepatitis C infection. Hepatology 22:1057-1064
50. Tsai S-L, Liaw Y-F, Yeh C-T, Chu C-M, Kuo GC (1995) Cellular immune responses in patients with dual infection of hepatitis B and C viruses: dominant role of hepatitis C virus. Hepatology 21:908-912
51. Leroux-Roels G, Esquivel CA, DeLeys R, Stuyver L, Elewaut A, Philippé J, Desombere I, Paradijs J, Maertens G (1996) Lymphoproliferative responses to hepatitis C virus core. E1, E2. and NS3 in patients with chronic hepatitis C infection treated with interferon alpha. Hepatology 23:8-16
52. + T-lymphocyte epitopes within the hepatitis C virus core protein. J Hepatol 21 [Suppl 1]:S5 (abstract)
53. Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, Eichenlaub D, Pape GR (1995) Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346:1006-1007
54. Missale G, Bertoni R, Valli A, Lamonaca V, Massari M, Berghenti F, Magnani G, Mori C, Fiaccadori F, Ferrari C (1995) Hepatitis C virus (HCV) specific T cell response: long-term follow up after acute hepatitis C. J Hepatol 23:126A (abstract)